Delivery Order SPE2DR25D2209-SPE2DR26FD6VJ
- Not listed
- The Defense Logistics Agency awarded a $30,633.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/ml ampules, with an ultimate completion date of September 26, 2025. This non-set-aside contract was competitively awarded and represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $17,133.09 to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Epinephrine 1 mg/mL ampules. This firm fixed-price, non-set-aside contract will be performed at the contractor's Conshohocken, Pennsylvania facility and is scheduled for completion by January 14, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through competitive procurement to...
- The Defense Logistics Agency awarded a $16,667.20 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/mL ampules, with an ultimate completion date of August 12, 2025. This firm fixed price contract was competitively awarded without set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a $3,366.00 delivery order to AmerisourceBergen Drug Corp for Epinephrine 1 mg/mL ampules on August 15, 2025, with an ultimate completion date of August 18, 2025. This non-set-aside contract employs firm fixed price terms and is being performed in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order represents a small-value transaction within AmerisourceBergen's broader federal medical supply portfolio and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 14, 2026, for the supply of Epinephrine 1 mg/ml ampules, with a ceiling value of $7,261.58 and an ultimate completion date of January 15, 2026. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,366.00 to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/ml ampules. This firm fixed-price, competitively awarded contract was executed on September 18, 2025, with an ultimate completion date of September 19, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $3,534.88 to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/mL ampules. This firm fixed-price, non-set-aside delivery order was awarded on September 26, 2025, with an ultimate completion date of September 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Epinephrine 1 mg/mL ampules valued at $6,111.22. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion on August 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $7,272.06 to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Epinephrine 1 mg/mL ampules. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award to the vendor. Performance will be completed at the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 9, 2026. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,122.00 to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/mL ampules. This non-competitive delivery order, issued on August 5, 2025, represents a firm fixed-price purchase under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. As a leading pharmaceutical distributor,...
- SPE2DR25D2209Indefinite Delivery Contract
- SPE2DR25D2209-SPE2DR26FD6VJDelivery Order
The Defense Logistics Agency awarded a $6,524.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Epinephrine 1 mg/ml ampules, with an award date of January 15, 2026 and an ultimate completion date of January 16, 2026. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. The contract carries no set-aside designation, indicating it was competitively awarded on a full and open basis. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. As a critical pharmaceutical distributor for federal medical procurement, AmerisourceBergen supplies essential medications and medical products to support military healthcare programs and the Defense Health Agency worldwide. Epinephrine ampules represent a critical emergency medication used across military treatment facilities and healthcare systems requiring immediate availability for life-threatening allergic reactions and anaphylaxis response protocols. This delivery order exemplifies the routine pharmaceutical replenishment activities conducted through DLA's comprehensive medical supply chain to maintain adequate inventory of essential medications across the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 1/14/26 |